Prevention of kidney transplant rejection

Prevention of kidney transplant rejection refers to the therapeutic suppression of the recipient's immune response to avoid immune-mediated injury and subsequent failure of a donor renal allograft Prophylaxis maintains target graft function and long-term organ survival by continuously inhibiting pathways of alloreactive immune recognition and effector cytotoxicity

Prevention of kidney transplant rejection refers to the therapeutic suppression of the recipient's immune response to avoid immune-mediated injury and subsequent failure of a donor renal allograft This clinical state occurs in kidney transplant recipients where foreign human leukocyte antigens on the donor organ provoke host cell-mediated and humoral immune reactions, predominantly driven by T-lymphocyte activation and donor-specific antibody production Left unmitigated, this alloimmune attack m...

This clinical state occurs in kidney transplant recipients where foreign human leukocyte antigens on the donor organ provoke host cell-mediated and humoral immune reactions, predominantly driven by T-lymphocyte activation and donor-specific antibody production

Left unmitigated, this alloimmune attack manifests pathologically as tubulitis, interstitial inflammation, vasculitis, or microvascular endothelial damage, clinically resulting in acute kidney injury, proteinuria, progressive allograft dysfunction, and graft loss

Prophylaxis maintains target graft function and long-term organ survival by continuously inhibiting pathways of alloreactive immune recognition and effector cytotoxicity